CD274 and breast carcinoma: In addition, the expression of PD-L1 in breast cancer stem cells has attracted interest in recent years, and studies have found a significant increase in PD-L1 protein in breast cancer stem cells; therefore, targeting PD-L1 in stem cells may become a new promising therapeutic strategy for breast cancer (104).